These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20139178)

  • 1. Upregulation of Oct-4 isoforms in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension.
    Firth AL; Yao W; Remillard CV; Ogawa A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2010 Apr; 298(4):L548-57. PubMed ID: 20139178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smooth muscle cell-specific FoxM1 controls hypoxia-induced pulmonary hypertension.
    Dai J; Zhou Q; Tang H; Chen T; Li J; Raychaudhuri P; Yuan JX; Zhou G
    Cell Signal; 2018 Nov; 51():119-129. PubMed ID: 30092353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated copper transporters in hypoxia-induced pulmonary hypertension.
    Zimnicka AM; Tang H; Guo Q; Kuhr FK; Oh MJ; Wan J; Chen J; Smith KA; Fraidenburg DR; Choudhury MS; Levitan I; Machado RF; Kaplan JH; Yuan JX
    PLoS One; 2014; 9(3):e90544. PubMed ID: 24614111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition.
    Tang H; Babicheva A; McDermott KM; Gu Y; Ayon RJ; Song S; Wang Z; Gupta A; Zhou T; Sun X; Dash S; Wang Z; Balistrieri A; Zheng Q; Cordery AG; Desai AA; Rischard F; Khalpey Z; Wang J; Black SM; Garcia JGN; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L256-L275. PubMed ID: 29074488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth.
    Covello KL; Kehler J; Yu H; Gordan JD; Arsham AM; Hu CJ; Labosky PA; Simon MC; Keith B
    Genes Dev; 2006 Mar; 20(5):557-70. PubMed ID: 16510872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-mediated downregulation of K
    Babicheva A; Ayon RJ; Zhao T; Ek Vitorin JF; Pohl NM; Yamamura A; Yamamura H; Quinton BA; Ba M; Wu L; Ravellette KS; Rahimi S; Balistrieri F; Harrington A; Vanderpool RR; Thistlethwaite PA; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2020 Jan; 318(1):L10-L26. PubMed ID: 31553627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA microarray and signal transduction analysis in pulmonary artery smooth muscle cells from heritable and idiopathic pulmonary arterial hypertension subjects.
    Yu J; Wilson J; Taylor L; Polgar P
    J Cell Biochem; 2015 Mar; 116(3):386-97. PubMed ID: 25290246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic role of calcium-sensing receptors in the development and progression of pulmonary hypertension.
    Tang H; Yamamura A; Yamamura H; Song S; Fraidenburg DR; Chen J; Gu Y; Pohl NM; Zhou T; Jiménez-Pérez L; Ayon RJ; Desai AA; Goltzman D; Rischard F; Khalpey Z; Black SM; Garcia JG; Makino A; Yuan JX
    Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(9):L846-59. PubMed ID: 26968768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of Na+/Ca2+ exchanger contributes to the enhanced Ca2+ entry in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
    Zhang S; Dong H; Rubin LJ; Yuan JX
    Am J Physiol Cell Physiol; 2007 Jun; 292(6):C2297-305. PubMed ID: 17192285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension.
    Kouri FM; Queisser MA; Königshoff M; Chrobak I; Preissner KT; Seeger W; Eickelberg O
    Int J Biochem Cell Biol; 2008; 40(9):1872-82. PubMed ID: 18337154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension.
    Hecker M; Zaslona Z; Kwapiszewska G; Niess G; Zakrzewicz A; Hergenreider E; Wilhelm J; Marsh LM; Sedding D; Klepetko W; Lohmeyer J; Dimmeler S; Seeger W; Weissmann N; Schermuly RT; Kneidinger N; Eickelberg O; Morty RE
    Am J Respir Crit Care Med; 2010 Sep; 182(6):805-18. PubMed ID: 20522789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-221-3p promotes pulmonary artery smooth muscle cells proliferation by targeting AXIN2 during pulmonary arterial hypertension.
    Nie X; Chen Y; Tan J; Dai Y; Mao W; Qin G; Ye S; Sun J; Yang Z; Chen J
    Vascul Pharmacol; 2019 May; 116():24-35. PubMed ID: 28694128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgelin as a therapeutic target to prevent hypoxic pulmonary hypertension.
    Zhang R; Shi L; Zhou L; Zhang G; Wu X; Shao F; Ma G; Ying K
    Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L574-83. PubMed ID: 24464808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G
    Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered Smooth Muscle Cell Histone Acetylome by the SPHK2/S1P Axis Promotes Pulmonary Hypertension.
    Ranasinghe ADCU; Holohan M; Borger KM; Donahue DL; Kuc RD; Gerig M; Kim A; Ploplis VA; Castellino FJ; Schwarz MA
    Circ Res; 2023 Sep; 133(8):704-719. PubMed ID: 37698017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased smooth muscle cell expression of caveolin-1 and caveolae contribute to the pathophysiology of idiopathic pulmonary arterial hypertension.
    Patel HH; Zhang S; Murray F; Suda RY; Head BP; Yokoyama U; Swaney JS; Niesman IR; Schermuly RT; Pullamsetti SS; Thistlethwaite PA; Miyanohara A; Farquhar MG; Yuan JX; Insel PA
    FASEB J; 2007 Sep; 21(11):2970-9. PubMed ID: 17470567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-23a regulates the proliferation and migration of human pulmonary artery smooth muscle cells (HPASMCs) through targeting BMPR2/Smad1 signaling.
    Zhang Y; Peng B; Han Y
    Biomed Pharmacother; 2018 Jul; 103():1279-1286. PubMed ID: 29864909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.
    Remillard CV; Tigno DD; Platoshyn O; Burg ED; Brevnova EE; Conger D; Nicholson A; Rana BK; Channick RN; Rubin LJ; O'connor DT; Yuan JX
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1837-53. PubMed ID: 17267549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.